CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors von CLEGG, A. O, ASHTON, L. J, BITI, R. A, BADHWAR, P, WILLIAMSON, P, KALDOR, J. M, STEWART, G. J

Volltext

Increased frequency of CCR-5 Δ32 heterozygotes among long-term non-progressors with HIV-1 infection von STEWART, G. J, ASHTON, L. J, BITI, R. A, FFRENCH, R. A, BENNETTS, B. H, NEWCOMBE, N. R, BENSON, E. M, CARR, A, COOPER, D. A, KALDOR, J. M

Volltext

HIV-Nef enhances interleukin-2 production and phosphatidylinositol 3-kinase activity in a human T cell line von SCHIBECI, S. D, CLEGG, A. O, BITI, R. A, SAGAWA, K, STEWART, G. J, WILLIAMSON, P

Volltext

T-cell response to HIV in natural infection: Optimized culture conditions for detecting responses to gag peptides von Adams, Susan L, Biti, Robyn A, Stewart, Graeme J

Volltext

T-cell response to HIV in natural infection : Optimized culture conditions for detecting responses to gag peptides von ADAMS, S. L, BITI, R. A, STEWART, G. J

Volltext

HIV-1 infection in an individual homozygous for the CCR5 deletion allele von Biti, Robyn, Ffrench, Rosemary, Young, Judy, Bennetts, Bruce, Stewart, Graeme, Liang, Tong

Volltext

Chemokine receptor genotype and response to interleukin-2 therapy in HIV-1-infected individuals von Clegg, Alison, Williamson, Peter, Biti, Robyn, Cooper, David, Emery, Sean, Carr, Andrew, Stewart, Graeme

Volltext